Whalegun
Home

Alnylam Pharmaceuticals ALNY spent $430K on lobbying in Q1 2026 · Medicare, Trade and 1 more issue

Trade details

Type
Lobbying report
Amount
$430,000
Quarter
Q1 2026
Stock
Alnylam Pharmaceuticals ALNY
Client
Alnylam Pharmaceuticals
Reported
26/04/20

Up 10.3% from last quarter

What else happened in Alnylam Pharmaceuticals around then

Filed or reported within 30 days of the trade day · 03/01~04/30

Alnylam Pharmaceuticals's other lobbying reports